Biopharmaceutical company Biocon’s shares fell 6% to Rs 320.80 in Thursday trade on the BSE after the firm reported a second-quarter loss, impacted by a deferred tax charge. The drugmaker’s net profit plunged 84.2% year-on-year (YoY) in Q2 to Rs 27.1 crore, sharply down from Rs 172 crore reported in the same quarter of the…
READ MOREDomestic markets experienced volatility on Wednesday and ended down nearly half a percent amid mixed signals. In today’s trade, shares of Tata Investment, Tata Power, L&T, Wipro, Biocon among others will be in focus due to news developments and second quarter results. Tata InvestmentShares of Tata Investment will be in focus in Thursday’s trade as…
READ MOREDomestic markets, after a lacklustre start on Tuesday, came under pressure and closed with losses, marking a second straight day in the red. “We expect the market to continue its consolidation mode due to the lack of any major positive trigger. However, investors should use this dip as a buying opportunity in quality stocks especially…
READ MOREFifteen stocks are under F&O trade ban on Tuesday viz. Aditya Birla Capital, Aditya Birla Fashion & Retail (ABFRL), Bandhan Bank, Biocon, Birlasoft, Granules India, Hindustan Copper, India Cements, Indiamart Intermesh, LIC Housing Finance, Manappuram Finance, Punjab National Bank (PNB), RBL Bank, Steel Authority of India (SAIL) and Sun TV Network. Gujarat Narmada Valley Fertilizers…
READ MORE